IL10 and renal cell carcinoma: A recent report showed that TAMs isolated from RCC displayed enhanced 15‐lipoxygenase‐2 (15‐LOX2) pathway activity and produced substantial amounts of CCL2 and IL‐10 that contribute to RCC‐related inflammation, immunosuppression, and malignant progression 39.